[Pre-Aug 2018] IMSCAR
- Paper › Research › Not peer-reviewed
- Published
Orphan drug treatments: economic considerations
Hughes, D. & Hughes, D. A., 1 Nov 2007.Research output: Contribution to conference › Paper
- Published
PIs' Predictions of UKATT Results.
Slegg, G. P. & Slegg, G., 1 Jan 2004.Research output: Contribution to conference › Paper
- Published
Participation in community arts for health and well-being of people with dementia, their carers, and the communities in which they live – implications for research, policy and practice
Windle, G., 11 Jul 2012.Research output: Contribution to conference › Paper
- Published
Patient compliance and persistence with prescribed medication: Measurement and health economic impact
Hughes, D., Koncz, T., Hughes, D. A., Cleemput, I. & Annemans, L., 1 May 2004.Research output: Contribution to conference › Paper
- Published
Patient compliance and pharmacoeconomics
Hughes, D. & Hughes, D. A., 1 Nov 2002.Research output: Contribution to conference › Paper
- Published
Patient compliance and pharmacoeconomics
Hughes, D. & Hughes, D. A., 1 Oct 2001.Research output: Contribution to conference › Paper
- Published
Pharmacoeconomic evaluations in Ireland, Scotland and Wales: A Celtic perspective on pharmaceutical assessment
Hughes, D., Hughes, D. A., Drummond, M., Tolley, K. & Ryan, M., 1 Oct 2007.Research output: Contribution to conference › Paper
- Published
Pharmacoeconomic models that incorporate non-compliance
Hughes, D. & Hughes, D. A., 1 Jul 2004.Research output: Contribution to conference › Paper
- Published
Pharmacoeconomics appraisals by the all Wales medicines strategy group
Hughes, D. & Hughes, D. A., 1 Jul 2004.Research output: Contribution to conference › Paper
- Published
Pharmacoeconomics in Wales: functions of the all Wales medicines strategy group
Hughes, D. & Hughes, D. A., 1 Apr 2004.Research output: Contribution to conference › Paper